[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE211650T1 - Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen - Google Patents

Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen

Info

Publication number
ATE211650T1
ATE211650T1 AT99902686T AT99902686T ATE211650T1 AT E211650 T1 ATE211650 T1 AT E211650T1 AT 99902686 T AT99902686 T AT 99902686T AT 99902686 T AT99902686 T AT 99902686T AT E211650 T1 ATE211650 T1 AT E211650T1
Authority
AT
Austria
Prior art keywords
treatment
lanolin
preparations containing
glyceryl trinitrate
topical preparations
Prior art date
Application number
AT99902686T
Other languages
English (en)
Inventor
Colin Anthony Kemp
Original Assignee
Futura Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Futura Medical Ltd filed Critical Futura Medical Ltd
Application granted granted Critical
Publication of ATE211650T1 publication Critical patent/ATE211650T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Drying Of Semiconductors (AREA)
  • Signal Processing For Digital Recording And Reproducing (AREA)
  • Prostheses (AREA)
  • Cosmetics (AREA)
AT99902686T 1998-01-30 1999-01-28 Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen ATE211650T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9802078.7A GB9802078D0 (en) 1998-01-30 1998-01-30 Preparation for treatment of erectile dysfunction
PCT/GB1999/000288 WO1999038506A2 (en) 1998-01-30 1999-01-28 Use of topical preparations of glyceryl trinitrate and lanolin for the treatment of erectile dysfunction

Publications (1)

Publication Number Publication Date
ATE211650T1 true ATE211650T1 (de) 2002-01-15

Family

ID=10826219

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99902686T ATE211650T1 (de) 1998-01-30 1999-01-28 Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen

Country Status (18)

Country Link
EP (2) EP0934744A1 (de)
JP (1) JP2002501893A (de)
KR (1) KR100595413B1 (de)
CN (1) CN1292691A (de)
AT (1) ATE211650T1 (de)
AU (1) AU747085B2 (de)
BR (1) BR9908358A (de)
CA (1) CA2319202A1 (de)
DE (1) DE69900774T2 (de)
DK (1) DK1049461T3 (de)
ES (1) ES2169942T3 (de)
GB (1) GB9802078D0 (de)
HK (1) HK1033647A1 (de)
ID (1) ID26132A (de)
IL (2) IL137561A0 (de)
NZ (1) NZ506580A (de)
PT (1) PT1049461E (de)
WO (1) WO1999038506A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE318563T1 (de) * 2001-03-30 2006-03-15 Futura Medical Dev Ltd Kondom mit einer erektogenen zusammensetzung
GB0417675D0 (en) 2004-08-09 2004-09-08 Futura Medical Dev Ltd Composition for promoting vascular smooth muscle relaxation
GB0602224D0 (en) 2006-02-03 2006-03-15 Futura Medical Dev Ltd Composition for promoting vascular smooth muscle relaxation
GB201121204D0 (en) 2011-12-09 2012-01-18 Lrc Products A pack containing a condom
CN104161617A (zh) * 2014-08-29 2014-11-26 蔺莹莹 一种新型避孕套及其制备方法
TW201927292A (zh) 2017-12-13 2019-07-16 大陸商上海小午醫藥科技有限公司 一種用於預防或治療與ｅｇｆｒ被抑制相關疾病的方法
EP3782618A4 (de) 2018-04-16 2022-01-26 OnQuality Pharmaceuticals China Ltd. Verfahren zur vorbeugung oder behandlung von nebenwirkungen einer krebstherapie

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5572108A (en) * 1978-11-27 1980-05-30 Sanwa Kagaku Kenkyusho:Kk Preparation for transcutaneous administration, composed mainly of nitroglycerine
US4450175A (en) * 1982-09-23 1984-05-22 Warshaw Thelma G Method and compositions for treating acne
IE54286B1 (en) * 1983-01-18 1989-08-16 Elan Corp Plc Drug delivery device
CA1328813C (en) * 1986-11-06 1994-04-26 Hiroshi Tanaka Skin irritation alleviation agent and composition thereof
US4829991A (en) * 1987-01-06 1989-05-16 Medical Engineering Corp. Method and device for stimulating an erection
LU87410A1 (fr) * 1988-12-20 1990-07-10 Cird Composition cosmetique ou pharmaceutique contenant des microspheres de polymeres ou de corps gras chargees d'au moins un produit actif
JPH02200633A (ja) * 1989-01-27 1990-08-08 Akamatsu Shoji Kk 血管拡張剤
BR9203277A (pt) * 1992-08-21 1994-03-01 Cesar Roberto Dias Nahoum Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao
US5698589A (en) * 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
RU2036644C1 (ru) * 1994-01-05 1995-06-09 Олег Борисович Лоран Средство для нормализации половой потенции мужчин

Also Published As

Publication number Publication date
KR20010040488A (ko) 2001-05-15
GB9802078D0 (en) 1998-03-25
CA2319202A1 (en) 1999-08-05
JP2002501893A (ja) 2002-01-22
ES2169942T3 (es) 2002-07-16
IL137561A (en) 2006-12-31
BR9908358A (pt) 2002-12-31
DK1049461T3 (da) 2002-04-15
KR100595413B1 (ko) 2006-07-03
WO1999038506A3 (en) 1999-09-30
AU2289899A (en) 1999-08-16
AU747085B2 (en) 2002-05-09
HK1033647A1 (en) 2001-09-14
EP0934744A1 (de) 1999-08-11
PT1049461E (pt) 2002-07-31
DE69900774D1 (de) 2002-02-28
EP1049461B1 (de) 2002-01-09
WO1999038506A2 (en) 1999-08-05
IL137561A0 (en) 2001-07-24
DE69900774T2 (de) 2002-08-14
ID26132A (id) 2000-11-23
CN1292691A (zh) 2001-04-25
EP1049461A2 (de) 2000-11-08
NZ506580A (en) 2003-05-30

Similar Documents

Publication Publication Date Title
CA2279967A1 (en) Method of enhancing hair growth
DE69733132D1 (de) Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
ATE349428T1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
ATE229502T1 (de) Arylsulfonamide und analoga und ihre verwendung zur behandlung von neurodegenerativen erkrankungen
DE59710494D1 (de) Kosmetisches Mittel zur Haarbehandlung mit Dendrimeren
ATE186834T1 (de) Verwendung von wirksamen mengen von aktiven stoffen zur behandlung von mischhaut
DE69830728D1 (de) Arzneimittel zur behandlung von häufigem wasserlassen und harninkontinenz
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE69526437D1 (de) Transdermal verabreichbare zubereitung zur behandlung von störungen des harnlassens
DE69806801D1 (de) Galenische präparation zur prävention und behandlung von hepatokarzinomen
DE3671365D1 (de) Topische anwendung des 3-phenylacetylamino-2,6-piperidindions zur behandlung von hautfalten und hyperpigmentierung.
DE69803200D1 (de) Verwendung von mindestens einen chrysanthemum gattungs extrakten zur förderung der haut- und/oder der haarepigmentierung
ATE211650T1 (de) Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
DE69402826D1 (de) Zusammensetzung zur haarpflege
DE69925578D1 (de) Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten
DE69822276D1 (de) Kräuter formulierung mit therapeutischer und kosmetischer verwendung zur behandlung von allgemeinen hauterkrankungen
DE69832722D1 (de) L-threonat-eisen, pharmazeutische zusammensetzung und verwendung zur verbesserung und behandlung von anämie bei menschen
ATE159171T1 (de) Arzneimittelzusammensetzung enthaltend tcf-ii
DE69309810D1 (de) Mittel zur förderung des haarwuchses und dessen wiederherstellung
ATE137967T1 (de) Verwendung von ketorolac zur behandlung von periodontitis
DE69427116D1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
IT1251497B (it) Uso di 1,2 dipalmitoil-l-alfa-fosfatidil-n,n-dimetiletanolammina, in composizioni dermatologiche
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
BR9704964A (pt) Uso de sulbutiamina para obter composições farmacêuticas úteis no tratamento de algumas pertubações psicomotoras e psico-intelectuais

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1049461

Country of ref document: EP

REN Ceased due to non-payment of the annual fee